Literature DB >> 31511612

Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.

Alexander K Chao1, Julia A Meyer1, Alex G Lee1, Anna Hecht1, Theodore Tarver2, Jessica Van Ziffle3, Ashley K Koegel1, Carla Golden4, Benjamin S Braun1,5, E Alejandro Sweet-Cordero1,5, Catherine C Smith2,5, Christopher C Dvorak1,5, Mignon L Loh1,5, Elliot Stieglitz6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31511612      PMCID： PMC6995757          DOI： 10.1038/s41375-019-0549-y

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.

Authors:  Anna Hecht; Julia Meyer; Farid F Chehab; Kristie L White; Kevin Magruder; Christopher C Dvorak; Mignon L Loh; Elliot Stieglitz
Journal:  Pediatr Blood Cancer       Date:  2019-07-26       Impact factor: 3.167

2.  ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML.

Authors:  Barbara Spitzer; Filemon S Dela Cruz; Glorymar D Ibanez Sanchez; Yanming Zhang; Wenbin Xiao; Ryma Benayed; Alina Markova; M Irene Rodriguez-Sanchez; Nancy Bouvier; Mikhail Roshal; Andrew L Kung; Neerav Shukla
Journal:  Blood Adv       Date:  2021-04-13

Review 3.  Updates on eosinophilic disorders.

Authors:  Alexandar Tzankov; Kaaren K Reichard; Robert P Hasserjian; Daniel A Arber; Attilio Orazi; Sa A Wang
Journal:  Virchows Arch       Date:  2022-09-07       Impact factor: 4.535

4.  CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out.

Authors:  Anna Dal Molin; Mattias Hofmans; Enrico Gaffo; Alessia Buratin; Hélène Cavé; Christian Flotho; Valerie de Haas; Charlotte M Niemeyer; Jan Stary; Pieter Van Vlierberghe; Jan Philippé; Barbara De Moerloose; Geertruij Te Kronnie; Silvia Bresolin; Tim Lammens; Stefania Bortoluzzi
Journal:  Front Cell Dev Biol       Date:  2021-01-06

5.  CCDC88C-FLT3 gene fusion in CD34-positive haematopoietic stem and multilineage cells in myeloid/lymphoid neoplasm with eosinophilia.

Authors:  Yuya Kurihara; Hideaki Mizuno; Akira Honda; Arika Shimura; Yosei Fujioka; Hiroaki Maki; Mineo Kurokawa
Journal:  J Cell Mol Med       Date:  2022-01-12       Impact factor: 5.310

Review 6.  Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia.

Authors:  Claudia Fiñana; Noel Gómez-Molina; Sandra Alonso-Moreno; Laura Belver
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

7.  EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.

Authors:  R J Leguit; A Orazi; N Kucine; H M Kvasnicka; U Gianelli; D A Arber; A Porwit; M Ponzoni
Journal:  Virchows Arch       Date:  2022-07-11       Impact factor: 4.535

8.  NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMML.

Authors:  Astrid Behnert; Alex G Lee; Elizabeth P Young; Marcus R Breese; Stanley G Leung; Inge Behroozfard; Maria Maruffi; E Alejandro Sweet-Cordero; Christopher C Dvorak; Julia Chu; Elliot Stieglitz
Journal:  J Pediatr Hematol Oncol       Date:  2021-08-01       Impact factor: 1.170

9.  Precision cancer monitoring using a novel, fully integrated, microfluidic array partitioning digital PCR platform.

Authors:  Megan E Dueck; Robert Lin; Andrew Zayac; Steve Gallagher; Alexander K Chao; Lingxia Jiang; Sammy S Datwani; Paul Hung; Elliot Stieglitz
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

10.  Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.

Authors:  Astrid Wintering; Christopher C Dvorak; Elliot Stieglitz; Mignon L Loh
Journal:  Blood Adv       Date:  2021-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.